z-logo
open-access-imgOpen Access
Development of Idarubicin and Doxorubicin Solid Lipid Nanoparticles to Overcome Pgp-Mediated Multiple Drug Resistance in Leukemia
Author(s) -
Ping Ma,
Xiaowei Dong,
Courtney L. Swadley,
Anshul Gupte,
Markos Leggas,
Harry C. Ledebur,
Russell J. Mumper
Publication year - 2009
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/n9v0-mp19
Subject(s) - idarubicin , solid lipid nanoparticle , doxorubicin , leukemia , drug , drug resistance , pharmacology , multiple drug resistance , chemistry , cancer research , medicine , chemotherapy , biology , immunology , microbiology and biotechnology , cytarabine

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom